FMR CORP 13D and 13G filings for OMEGA THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-07 09:57 am Sale |
2025-02-28 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
FMR CORP | 0 0.000% |
-5,888,549 (Position Closed) |
Filing |
| 2024-02-12 12:03 pm Purchase |
2024-02-09 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
FMR CORP | 5,888,549 10.678% |
601,974 (+11.39%) |
Filing |
| 2024-02-09 09:28 am Sale |
2024-02-08 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
FMR CORP | 5,286,575 9.587% |
-271,003 (-4.88%) |
Filing |
| 2023-03-10 09:30 am Purchase |
2023-03-09 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
FMR CORP | 5,557,578 10.102% |
958,135 (+20.83%) |
Filing |
| 2023-02-09 12:01 pm Purchase |
2023-02-09 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
FMR CORP | 4,599,443 9.572% |
169,762 (+3.83%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | OMEGA THERAPEUTICS INC OMGAQ |
FMR CORP | 4,429,681 9.271% |
4,429,681 (New Position) |
Filing |